KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Net Margin (2016 - 2025)

Historic Net Margin for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 8.84%.

  • BeOne Medicines' Net Margin rose 209600.0% to 8.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year increase of 273200.0%. This contributed to the annual value of 16.92% for FY2024, which is 189400.0% up from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Net Margin is 8.84%, which was up 209600.0% from 7.17% recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Net Margin peaked at 27.57% during Q3 2023, and registered a low of 320.24% during Q2 2021.
  • Moreover, its 5-year median value for Net Margin was 57.94% (2023), whereas its average is 83.9%.
  • As far as peak fluctuations go, BeOne Medicines' Net Margin soared by 7405000bps in 2021, and later plummeted by -1529100bps in 2022.
  • Quarter analysis of 5 years shows BeOne Medicines' Net Margin stood at 276.04% in 2021, then surged by 58bps to 117.16% in 2022, then soared by 51bps to 57.94% in 2023, then surged by 77bps to 13.47% in 2024, then skyrocketed by 166bps to 8.84% in 2025.
  • Its last three reported values are 8.84% in Q3 2025, 7.17% for Q2 2025, and 0.11% during Q1 2025.